Type of LTCs | N = 500,769. Adjusted analyses* (missing values n = 12,045; 2.4%) | ||
---|---|---|---|
Hazard ratios (95% confidence intervals) for All-cause mortality | Hazard ratios (95% confidence intervals) for cancer mortality | Hazard ratios (95% confidence intervals) for vascular mortality | |
No cardiometabolic conditions | 1 | 1 | 1 |
 1 LTC-cardiometabolic | 1.19 (1.15–1.24) | 1.04 (0.99–1.10) | 1.79 (1.63–1.96) |
 2 LTC-cardiometabolic | 1.67 (1.58–1.77) | 1.15 (1.06–1.24) | 3.42 (3.06–3.82) |
 3 LTC-cardiometabolic | 2.52 (2.31–2.76) | 1.23 (1.05–1.44) | 7.31 (6.32–8.46) |
 ≥ 4 LTC-cardiometabolic | 3.20 (2.56–4.00) | 1.67 (1.12–2.51) | 8.20 (5.81–11.58) |
No previous cancer | 1 | 1 | 1 |
Presence history of Cancer | 2.83 (2.71–2.95) | 4.26 (4.06–4.47) | 0.99 (0.87–1.13) |
No non-cardiometabolic condition | 1 | 1 | 1 |
 1 LTC (excluding cancer and cardiometabolic) | 1.08 (1.04–1.12) | 0.99 (0.95–1.04) | 1.02 (0.94–1.11) |
 2 LTCs (excluding cancer and cardiometabolic) | 1.16 (1.10–1.22) | 0.98 (0.92–1.05) | 1.15 (1.03–1.29) |
 3 LTCs (excluding cancer and cardiometabolic) | 1.25 (1.16–1.35) | 0.96 (0.86–1.07) | 1.29 (1.10–1.52) |
 4 LTCs (excluding cancer and cardiometabolic) | 1.50 (1.36–1.67) | 0.89 (0.75–1.05) | 1.62 (1.31–1.99) |